Search

Your search keyword '"Moris L"' showing total 203 results

Search Constraints

Start Over You searched for: Author "Moris L" Remove constraint Author: "Moris L"
203 results on '"Moris L"'

Search Results

1. Correlation between the location of the index tumour and the location of positive lymph nodes in high-risk prostate cancer – a monocentric positive lymph node mapping study

3. How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis

4. How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis

5. The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer

6. Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium

7. Diagnostic and prognostic factors in patients with prostate cancer: a systematic review

8. Introducing PIONEER: a project to harness big data in prostate cancer research

9. Re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304–6: Prebiopsy MRI: Through the Looking Glass

10. Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research (Nature Reviews Urology, (2020), 17, 6, (351-362), 10.1038/s41585-020-0324-x)

13. The role of nuclear export in primary high-risk prostate cancer: A genomic analysis identifies XPO1 as potential therapeutic agent in high risk prostate cancer

14. Diagnostic and prognostic factors in patients with prostate cancer

15. Evaluation of oncological outcomes and data quality in studies assessing nerve sparing versus non-nerve sparing radical prostatectomy in non-metastatic prostate cancer: A systematic review

16. A systematic review on the impact of surgeon and hospital caseload volume on oncological and non-oncological outcomes after radical prostatectomy for non-metastatic prostate cancer

17. The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer

18. Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol

20. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

21. Re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.016: Prebiopsy MRI: Through the Looking Glass

22. PT348 - Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: A systematic review

23. PIONEER’s operational definitions: Harmonising clinical characteristics and phenotypes data of prostate cancer patients

24. PIONEER consensus on clinician reported outcome measurements

25. Initial steps of an online search tool development for diagnostic and prognostic factors in prostate cancer

26. The EAU biochemical recurrence risk stratification after radical prostatectomy

29. Current treatment options for locally advanced prostate cancer: EAU (-SIOG) guidelines view and recommendations

30. The Cancer Of the Bladder Risk Assessment (COBRA) score for estimating cancer-specific survival after radical cystectomy: External validation in a large bi-institutional European cohort

31. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)

32. Liraglutide and Renal Outcomes in Type 2 Diabetes

35. Genomic analysis of localized high-risk prostate cancer identifies XPO1 as a potential driver mechanism of metastatic progression

40. Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: A systematic review

41. Effect of lidocaine and substance P on migration and proliferation 'in vitro' of human adipose derived stem cells (HascS) and breast cancer cells (mda-mb-231)

42. Serum IL-6,IL- 10 and substance P concentrations of patients administered distint anaesthetic techniques in breast cancer surgery

44. Correlation between the location of the index tumour and the location of positive lymph nodes in high-risk prostate cancer. A monocentric positive lymph node mapping study

45. Feasibility of complete urinary tract extirpation

46. Genomic analysis of primary high-risk prostate cancer tumors with metastatic recurrence identifies antizyme inhibitor 1 as a regulator of cancer cell migration through regulation of collagen expression

49. The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer.

50. P058 - Initial steps of an online search tool development for diagnostic and prognostic factors in prostate cancer

Catalog

Books, media, physical & digital resources